Innovative Medicines Canada Responds to Today’s Speech from the Throne

OTTOWA, ON / ACCESSWIRE / September 23, 2020 / Pamela Fralick, President of Innovative Medicines Canada, issued the following statement in response to today’s Speech from the Throne:

“COVID-19 has shown just how critical the life sciences sector is to Canadians’ health and well-being. Today’s Throne Speech further acknowledged its importance with its focus on ensuring Canadians have access to the medicines they need, when they need them, particularly those with rare diseases.

“Canada’s innovative medicines sector is also committed to ensuring Canadians have access to the medicines and vaccines they need to live longer, healthier lives. That is why, over the last five years we have put forward to the federal and provincial governments concrete proposals that will ensure Canadians have timely access to the world’s most innovative medicines, including those for rare diseases. The proposals will also ensure that Canada remains an attractive place for clinical trials and new drug launches, in addition to fostering health care innovation at home and attracting investment from abroad.

“We look forward to hearing more details of the government’s plans as they work to implement the commitments they have made today. As always, Canada’s innovative medicines companies stand ready to work collaboratively with the federal and provincial governments to develop and implement solutions that will benefit all Canadians, throughout the current public health crisis and beyond.”

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

For further information:

Samantha Thompson
Media Relations
Telephone: 613-790-4555
E-mail: sthompson@imc-mnc.ca

SOURCE: Innovative Medicines Canada

View source version on accesswire.com:
https://www.accesswire.com/607526/Innovative-Medicines-Canada-Responds-to-Todays-Speech-from-the-Throne

Staff

Recent Posts

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX…

1 hour ago

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX…

1 hour ago

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

4 hours ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

4 hours ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

4 hours ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

4 hours ago